Payments to Acquire Property, Plant, and Equipment of Viridian Therapeutics, Inc.\DE from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Viridian Therapeutics, Inc.\DE annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Viridian Therapeutics, Inc.\DE Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $86,000.
  • Viridian Therapeutics, Inc.\DE annual Payments to Acquire Property, Plant, and Equipment for 2025 was $495,000, a 3.1% decline from 2024.
  • Viridian Therapeutics, Inc.\DE annual Payments to Acquire Property, Plant, and Equipment for 2024 was $511,000, a 43% decline from 2023.
  • Viridian Therapeutics, Inc.\DE annual Payments to Acquire Property, Plant, and Equipment for 2023 was $898,000, a 13% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Viridian Therapeutics, Inc.\DE Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $495,000 -$16,000 -3.1% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $511,000 -$387,000 -43% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $898,000 +$101,000 +13% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $797,000 +$459,000 +136% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $338,000 +$296,000 +705% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $42,000 -$42,000 -50% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
2019 $84,000 -$361,000 -81% 01 Jan 2019 31 Dec 2019 10-K 26 Mar 2021 2020 FY
2018 $445,000 +$199,000 +81% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
2017 $246,000 -$4,000 -1.6% 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019 2018 FY
2016 $250,000 +$127,000 +103% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 $123,000 -$143,000 -54% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017 2016 FY
2014 $266,000 +$261,000 +5220% 01 Jan 2014 31 Dec 2014 10-K 21 Mar 2016 2015 FY
2013 $5,000 01 Jan 2013 31 Dec 2013 10-K 27 Mar 2015 2014 FY

Viridian Therapeutics, Inc.\DE Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $86,000 +$86,000 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $0 -$115,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $115,000 -$64,000 -36% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $179,000 +$164,000 +1093% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $15,000 +$15,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q1 2020 $0 -$37,000 -100% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $37,000 -$58,000 -61% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $95,000 +$51,000 +116% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $44,000 -$61,000 -58% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $105,000 +$61,000 +139% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q1 2015 $44,000 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.